PARIS (AFP) - Researchers have broken the code of an enzyme that plays a key role in the growth of most cancers, opening a path that potentially leads to a new class of anti-cancer drugs, according to a study released Sunday.
PARIS (AFP) - Researchers have broken the code of an enzyme that plays a key role in the growth of most cancers, opening a path that potentially leads to a new class of anti-cancer drugs, according to a study released Sunday.
